Cargando…

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

Chronic hepatitis B (CHB) seriously threatens human health. About 820,000 deaths annually are due to related complications such as hepatitis B and hepatocellular carcinoma (HCC). Recently, the use of oral antiviral agents has significantly improved the prognosis of patients with CHB infection and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jung Hwan, Cho, Soon Gu, Jin, Young-Joo, Lee, Jin-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293610/ https://www.ncbi.nlm.nih.gov/pubmed/34823308 http://dx.doi.org/10.3350/cmh.2021.0281

Ejemplares similares

Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area
por: Shin, Jongbeom, et al.
Publicado: (2021)

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
por: Lee, Jaemin, et al.
Publicado: (2016)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance
por: Lee, Chung Seop, et al.
Publicado: (2018)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
por: Shim, Jae-Jun, et al.
Publicado: (2016)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report
por: Kim, Shin Il, et al.
Publicado: (2016)

Hepatic Splenosis Preoperatively Diagnosed as Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B: A Case Report
por: Choi, Gi-Hong, et al.
Publicado: (2008)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
por: Kim, Cha Young, et al.
Publicado: (2017)

Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
por: Hsu, Axel, et al.
Publicado: (2011)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden
por: Singh, Satender Pal, et al.
Publicado: (2022)

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

A Case of Hepatic Angiomyolipoma Which Was Misdiagnosed as Hepatocellular Carcinoma in a Hepatitis B Carrier
por: Hwang, Jin Yeon, et al.
Publicado: (2012)

Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma
por: Karaoglu, Diren Arda, et al.
Publicado: (2023)

Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
por: Kim, In Jung, et al.
Publicado: (2022)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
por: Shim, Chang Woo, et al.
Publicado: (2017)

Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Chun, Ho Soo, et al.
Publicado: (2021)

Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance
por: Jang, Sangmi, et al.
Publicado: (2023)

Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Jeong, Jae Yoon, et al.
Publicado: (2017)

Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma
por: Suh, Young Ju, et al.
Publicado: (2021)

High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study
por: Zhou, Jin-Yong, et al.
Publicado: (2012)

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population
por: Ma, Ning, et al.
Publicado: (2023)

Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma
por: Kang, Seung Ji, et al.
Publicado: (2018)

A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
por: Sinn, Dong Hyun, et al.
Publicado: (2017)

Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
por: Lim, Jung Hyun, et al.
Publicado: (2021)

Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
por: Lin, Yu-Ju, et al.
Publicado: (2013)

Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
por: Kim, Sung Eun
Publicado: (2017)

Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
por: Lee, Ji Hun, et al.
Publicado: (2022)

Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database
por: Cha, Boram, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4792lbk3i9rlerfgi10kj2u6be